137 related articles for article (PubMed ID: 30315214)
21. Xenopus pax6 mutants affect eye development and other organ systems, and have phenotypic similarities to human aniridia patients.
Nakayama T; Fisher M; Nakajima K; Odeleye AO; Zimmerman KB; Fish MB; Yaoita Y; Chojnowski JL; Lauderdale JD; Netland PA; Grainger RM
Dev Biol; 2015 Dec; 408(2):328-44. PubMed ID: 25724657
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of patients with aniridia in Russian Federation broadens the spectrum of PAX6 mutations.
Vasilyeva TA; Voskresenskaya AA; Käsmann-Kellner B; Khlebnikova OV; Pozdeyeva NA; Bayazutdinova GM; Kutsev SI; Ginter EK; Semina EV; Marakhonov AV; Zinchenko RA
Clin Genet; 2017 Dec; 92(6):639-644. PubMed ID: 28321846
[TBL] [Abstract][Full Text] [Related]
23. Modeling of Aniridia-Related Keratopathy by CRISPR/Cas9 Genome Editing of Human Limbal Epithelial Cells and Rescue by Recombinant PAX6 Protein.
Roux LN; Petit I; Domart R; Concordet JP; Qu J; Zhou H; Joliot A; Ferrigno O; Aberdam D
Stem Cells; 2018 Sep; 36(9):1421-1429. PubMed ID: 29808941
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis of PAX6 gene in a large Chinese family with aniridia.
Song SJ; Liu YZ; Cong RC; Jin Y; Hou ZQ; Ma ZZ; Ren GC; Li LS
Chin Med J (Engl); 2005 Feb; 118(4):302-6. PubMed ID: 15740668
[TBL] [Abstract][Full Text] [Related]
25. PAX6 aniridia syndrome: clinics, genetics, and therapeutics.
Lim HT; Kim DH; Kim H
Curr Opin Ophthalmol; 2017 Sep; 28(5):436-447. PubMed ID: 28598868
[TBL] [Abstract][Full Text] [Related]
26. Variants in TRIM44 Cause Aniridia by Impairing PAX6 Expression.
Zhang X; Qin G; Chen G; Li T; Gao L; Huang L; Zhang Y; Ouyang K; Wang Y; Pang Y; Zeng B; Yu L
Hum Mutat; 2015 Dec; 36(12):1164-7. PubMed ID: 26394807
[TBL] [Abstract][Full Text] [Related]
27. PAX6 gene mutations and genotype-phenotype correlations in sporadic cases of aniridia from India.
Dharmaraj N; Reddy A; Kiran V; Mandal A; Panicker S; Chakrabarti S
Ophthalmic Genet; 2003 Sep; 24(3):161-5. PubMed ID: 12868034
[TBL] [Abstract][Full Text] [Related]
28. Ritanserin, a potent serotonin 2A receptor antagonist, represses MEK/ERK signalling pathway to restore PAX6 production and function in aniridia-like cellular model.
Oved K; Zennaro L; Dorot O; Zerbib J; Frank E; Roux LN; Bremond-Gignac D; Pichinuk E; Aberdam D
Biochem Biophys Res Commun; 2021 Dec; 582():100-104. PubMed ID: 34700241
[TBL] [Abstract][Full Text] [Related]
29. Correlation of novel PAX6 gene abnormalities in aniridia and clinical presentation.
Sannan NS; Gregory-Evans CY; Lyons CJ; Lehman AM; Langlois S; Warner SJ; Zakrzewski H; Gregory-Evans K
Can J Ophthalmol; 2017 Dec; 52(6):570-577. PubMed ID: 29217025
[TBL] [Abstract][Full Text] [Related]
30. [Identification of a novel PAX6 mutation in a sporadic case with congenital aniridia].
Zhang C; Hao S; Zhang Q; Zhou B; Liu F; Lin X; Yan Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jun; 36(6):616-619. PubMed ID: 31055820
[TBL] [Abstract][Full Text] [Related]
31. Missense mutations in the DNA-binding region and termination codon in PAX6.
Chao LY; Mishra R; Strong LC; Saunders GF
Hum Mutat; 2003 Feb; 21(2):138-45. PubMed ID: 12552561
[TBL] [Abstract][Full Text] [Related]
32. Three novel PAX6 mutations in patients with aniridia.
Zumkeller W; Orth U; Gal A
Mol Pathol; 2003 Jun; 56(3):180-3. PubMed ID: 12782766
[TBL] [Abstract][Full Text] [Related]
33. Aniridia due to a novel microdeletion affecting
Syrimis A; Nicolaou N; Alexandrou A; Papaevripidou I; Nicolaou M; Loukianou E; Christophidou-Anastasiadou V; Malas S; Sismani C; Tanteles GA
J Genet; 2018 Jun; 97(2):555-562. PubMed ID: 29932076
[TBL] [Abstract][Full Text] [Related]
34. Clinical and molecular aspects of aniridia.
Kokotas H; Petersen MB
Clin Genet; 2010 May; 77(5):409-20. PubMed ID: 20132240
[TBL] [Abstract][Full Text] [Related]
35. [Study of genetic mutation locus in a family with congenital aniridia].
Cong RC; Song SJ; Liu YZ
Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1113-7. PubMed ID: 17415970
[TBL] [Abstract][Full Text] [Related]
36. A deletion 3' to the PAX6 gene in familial aniridia cases.
D'Elia AV; Pellizzari L; Fabbro D; Pianta A; Divizia MT; Rinaldi R; Grammatico B; Grammatico P; Arduino C; Damante G
Mol Vis; 2007 Jul; 13():1245-50. PubMed ID: 17679951
[TBL] [Abstract][Full Text] [Related]
37. PAX6 mutations: genotype-phenotype correlations.
Tzoulaki I; White IM; Hanson IM
BMC Genet; 2005 May; 6():27. PubMed ID: 15918896
[TBL] [Abstract][Full Text] [Related]
38. Ocular and craniofacial phenotypes in a large Brazilian family with congenital aniridia.
Fernandes-Lima ZS; Paixão-Côrtes VR; Andrade AK; Fernandes AS; Coronado BN; Monte Filho HP; Santos MJ; Omena Filho RL; Biondi FC; Ruiz-Linares A; Ramallo V; Hünemeier T; Schuler-Faccini L; Monlleó IL
Clin Genet; 2015; 87(1):68-73. PubMed ID: 24266705
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel frameshift mutation in
Palayil I; Priya SG; Sivan NVS; Madhivanan N; Venkatachalam PS; Jagadeesan M
Indian J Ophthalmol; 2018 Feb; 66(2):229-232. PubMed ID: 29380764
[TBL] [Abstract][Full Text] [Related]
40. Screening of PAX6 gene in Italian congenital aniridia patients revealed four novel mutations.
Primignani P; Allegrini D; Manfredini E; Romitti L; Mauri L; Patrosso MC; Veniani E; Franzoni A; Del Longo A; Gesu GP; Piozzi E; Damante G; Penco S
Ophthalmic Genet; 2016 Sep; 37(3):307-13. PubMed ID: 26849621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
